Apeloa Pharmaceutical Co Ltd (000739) — Financial Flexibility Index
Apeloa Pharmaceutical Co Ltd (000739) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of CN¥612.91 Million (operating CF CN¥446.18 Million minus capex CN¥166.73 Million) represents 0% of total liabilities (CN¥5.97 Billion). Check Apeloa Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Apeloa Pharmaceutical Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Apeloa Pharmaceutical Co Ltd across 28 annual periods. See Apeloa Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Apeloa Pharmaceutical Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Apeloa Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 000739 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.27x | CN¥1.62 Billion | CN¥1.23 Billion | CN¥5.97 Billion | ▼ -3.0% |
| 2024 | 0.28x | CN¥1.67 Billion | CN¥1.21 Billion | CN¥5.98 Billion | ▲ +9.8% |
| 2023 | 0.25x | CN¥1.66 Billion | CN¥1.03 Billion | CN¥6.54 Billion | ▼ -9.9% |
| 2022 | 0.28x | CN¥1.84 Billion | CN¥1.33 Billion | CN¥6.50 Billion | ▼ -14.4% |
| 2021 | 0.33x | CN¥1.31 Billion | CN¥611.75 Million | CN¥3.98 Billion | ▼ -25.7% |
| 2020 | 0.44x | CN¥1.38 Billion | CN¥1.06 Billion | CN¥3.10 Billion | ▼ -12.2% |
| 2019 | 0.51x | CN¥1.39 Billion | CN¥1.36 Billion | CN¥2.75 Billion | ▲ +33.0% |
| 2018 | 0.38x | CN¥914.32 Million | CN¥832.69 Million | CN¥2.41 Billion | ▲ +168.9% |
| 2017 | 0.14x | CN¥373.22 Million | CN¥209.80 Million | CN¥2.64 Billion | ▼ -17.1% |
| 2016 | 0.17x | CN¥511.77 Million | CN¥180.42 Million | CN¥3.00 Billion | ▼ -43.2% |
| 2015 | 0.30x | CN¥893.23 Million | CN¥441.16 Million | CN¥2.98 Billion | ▼ -37.7% |
| 2014 | 0.48x | CN¥1.33 Billion | CN¥786.64 Million | CN¥2.76 Billion | ▲ +94.2% |
| 2013 | 0.25x | CN¥695.45 Million | CN¥190.45 Million | CN¥2.80 Billion | ▲ +0.6% |
| 2012 | 0.25x | CN¥675.49 Million | CN¥335.90 Million | CN¥2.74 Billion | ▼ -14.9% |
| 2011 | 0.29x | CN¥693.83 Million | CN¥404.62 Million | CN¥2.40 Billion | ▲ +15.0% |
| 2010 | 0.25x | CN¥260.85 Million | CN¥121.05 Million | CN¥1.04 Billion | ▼ -20.4% |
| 2009 | 0.32x | CN¥301.95 Million | CN¥208.30 Million | CN¥954.91 Million | ▼ -30.6% |
| 2008 | 0.46x | CN¥443.61 Million | CN¥94.57 Million | CN¥973.00 Million | ▲ +35.9% |
| 2007 | 0.34x | CN¥289.90 Million | CN¥174.20 Million | CN¥864.02 Million | ▲ +30.4% |
| 2006 | 0.26x | CN¥213.27 Million | CN¥159.43 Million | CN¥828.68 Million | ▼ -9.8% |
| 2005 | 0.29x | CN¥209.05 Million | CN¥87.40 Million | CN¥732.94 Million | ▲ +33.7% |
| 2004 | 0.21x | CN¥158.61 Million | CN¥47.54 Million | CN¥743.40 Million | ▼ -41.1% |
| 2003 | 0.36x | CN¥193.45 Million | CN¥105.36 Million | CN¥534.24 Million | ▲ +186.2% |
| 2002 | 0.13x | CN¥50.05 Million | CN¥2.81 Million | CN¥395.59 Million | ▲ +8937.8% |
| 2001 | 0.00x | CN¥458.70K | CN¥-569.79K | CN¥327.67 Million | ▼ -97.6% |
| 2000 | 0.06x | CN¥10.30 Million | CN¥7.08 Million | CN¥177.79 Million | ▲ +196.7% |
| 1999 | -0.06x | CN¥-12.72 Million | CN¥-20.52 Million | CN¥212.40 Million | ▼ -129.2% |
| 1998 | 0.20x | CN¥46.53 Million | CN¥30.10 Million | CN¥227.17 Million | — |